HörerJCleuziouJKasner-SamprecJ. A comparative histopathological stud of heparin coated and uncoated polytetrafluoroethylene shunts in children with congenital heart disease. World J Pediatr Congenit Heart Surg. 2014;5(3):385–390.
2.
HuglBNevelsteenADaenensK. PEPE II—a multicenter study with an end-point heparin-bonded expanded polytetrafluoroethylen vascular graft for above and below knee bypass surgery: determinants of patency. J Cardiovasc Surg (Torino). 2009;50(2):195–203.
3.
LinPHBushRLYaoQLumsdenABChenC. Evaluation of platelet deposition and neointimal hyperplasia of heparin-coated small-caliber ePTFE grafts in a canine femoral artery bypass model. J Surg Res. 2004;118(1):45–52.
4.
LinPHChenCBushRLYaoQLumsdenABHansonSR. Small-caliber heparin-coated ePTFE grafts reduce platelet deposition and neointimal hyperplasia in a baboon model. J Vasc Surg. 2004;39(6):1322–1328.
5.
LindholtJSGottschalksenBJohannesenN. The Scandinavian Propaten((R)) trial—1-year patency of PTFE vascular prostheses with heparin-bonded luminal surfaces compared to ordinary pure PTFE vascular prostheses—a randomised clinical controlled multi-centre trial. Eur J Vasc Endovasc Surg. 2011;41(5):668–673.
6.
PulliRDorigoWCastelliP. Midterm results from a multicenter registry on the treatment of infrainguinal critical limb ischemia using a heparin-bonded ePTFE graft. J Vasc Surg. 2010;51(5):1167–1177.e1.
7.
LiJSYowEBereznyKY. Clinical outcomes of palliative surgery including a systemic-to-pulmonary artery shunt in infants with cyanotic congenital heart disease: does aspirin make a difference?Circulation. 2007;116(3):293–297.
8.
MyersJWGhanayemNSCaoY. Outcomes of systemic to pulmonary artery shunts in patients weighing less than 3 kg: analysis of shunt type, size, and surgical approach. J Thorac Cardiovasc Surg. 2014;147(2):672–677.
9.
WaniewskiJKurowskaWMizerskiJK. The effects of graft geometry on the patency of a systemic-to-pulmonary shunt: a computational fluid dynamics study. Artif Organs. 2005;29(8):642–650.
